Healthcare & Pharmaceuticals
🟢 SERP-Grounded (Light Telemetry)
Insmed
Programmatic AI Search & Model Visibility Audit
Share of Model (SOM)The percentage of time frontier AI models (ChatGPT, Claude, Gemini) recommend this brand for high-intent category queries.
3.0%
+1.2% 30-Day MomentumThe rolling 30-day change in algorithmic Share of Model. Positive momentum indicates increasing AI mindshare.
🧠 Neural Valency:VulnerableThe contextual sentiment of the AI's recommendation. 'Dominant' implies strong conviction, while 'Vulnerable' implies the model heavily conditions its recommendation.
Algorithmic Threat Detection
Primary Competitor Threat
Alexion Pharmaceuticals
Competitor Displacement Rate
18.0%
Competitors are displacing Insmed in 18.0% of high-intent buyer queries.The frequency at which AI models actively suggest a competitor as a superior alternative to this brand.
Algorithmic Rationale: Competitors are showing stronger efficacy data and broader approved indications for rare genetic diseases. Insmed's current portfolio may be perceived as less comprehensive.
Missing AI Citations:High-authority domains (e.g., Reddit, G2) that models cite to justify recommending competitors, where this brand currently lacks presence.
[alexion.com][genzyme.com]⚠️ Identified Vulnerability:Pipeline Breadth
Primary Threat Identified:Alexion Pharmaceuticals
Target Persona:Rare Disease Specialists
🚨 Threat Velocity:7/10An algorithmic urgency score (1-10) indicating how rapidly competitors are capturing this brand's historical AI search share.
Unlock Full Threat Report (30 Free Credits)